Anticancer agent 260
Anticancer agent 260 (Compound 3g/4d) is an orally active anticancer agent, that inhibits the proliferation of cancer cell HCT-116, MIA-PaCa2 and MDA-MB231 with IC50s of 98.7, 81.0, and 77.2 µg/mL, respectively. Anticancer agent 260 exhibits promotes ulcer formation and lipid peroxidation, anti-inflammatory and analgesic efficacy[1][2].
Product Specifications
CAS Number
345994-70-9
UNSPSC
12352005
Target
Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Field of Research
Cancer; Inflammation/Immunology; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-260.html
Smiles
CC1=C(C=CC=C1)C2=NN=C(C3=CC=NC=C3)O2
Molecular Formula
C14H11N3O
Molecular Weight
237.26
References & Citations
[1]Gilani SJ, et al., Synthesis and pharmacological evaluation of condensed heterocyclic 6-substituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole and 1,3,4-oxadiazole derivatives of isoniazid. Bioorg Med Chem Lett. 2010 Aug 15;20 (16) :4762-5. |[2]Mutchu B R, et al. Bi (OTf) 3 PROMOTED MICROWAVE SYNTHESIS OF 2-ARYL, 5-SUBSTITUTED 1, 3, 4-OXADIAZOLES AND EVALUATION OF THEIR ANTICANCER ACTIVITY[J]. organic synthesis, 2019, 12 (4) : 2052-2057.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP11913PU-N 400 µL
Cripto1 (TDGF1) (N-term) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
BNC941812-100 1x 100 µL
MART-1 / Melan-A / MLANA (Melanoma Marker) (rMLANA/788), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
